Meeting
2020 Gastrointestinal Cancers Symposium
Conversion gastrectomy for stage IV unresectable gastric cancer: A retrospective cohort study.
Authors
Tamotsu Sagawa
Division of Gastroenterology, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan
Tamotsu Sagawa , Yasushi Sato , Kyoko Hamaguchi , Masahiro Hirakawa , Hiroyuki Nagashima , Eriko Waga , Koshi Fujikawa , Yasuo Takahashi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Esophageal and Gastric Cancer and Other GI Cancers
Track
Esophageal and Gastric Cancer,Other GI Cancer
Sub Track
Patient-Reported Outcomes and Real-World Evidence
Citation
J Clin Oncol 38, 2020 (suppl 4; abstr 298)
Abstract #
298
Poster Bd #
A17
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
International retrospective cohort study of conversion therapy for stage IV gastric cancer 1 (CONVO-GC-1).
First Author: Masanori Terashima
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Impact of DNA mismatch repair status on prognosis of patients with locally advanced gastric cancer in a Mexican population.
First Author: Maria del Consuelo Diaz Romero
Poster
2024 ASCO Gastrointestinal Cancers Symposium
A modified triplet combination of docetaxel, oxaliplatin, and fluorouracil for gastric cancer (GC) with peritoneal carcinomatosis (PC) and inoperable malignant bowel obstruction (MBO): A multi-center, non-randomized, three-cohort, phase II trial (Zhen Jing).
First Author: Jian Xiao
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Prognostic impact of ectopic fat deposition within psoas muscle in patients undergoing systemic chemotherapy for stage IV gastric cancer.
First Author: Takako Ikegami